Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | BMY | AMGN | GILD | VRTX |
| Company | Inhibrx Biosciences Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 17.39 | 49.29 | 335.15 | 83.26 | 474.36 |
| High | 17.39 | 49.53 | 338.97 | 83.99 | 474.93 |
| Low | 16.23 | 49.00 | 334.27 | 82.75 | 463.81 |
| Last | 16.28 | 49.41 | 337.38 | 83.94 | 464.92 |
| Change | -1.21 | +0.39 | +1.43 | +0.04 | -12.98 |
| % Change | -6.92% | +0.80% | +0.43% | +0.05% | -2.72% |
| Volume | 302,000 | 27,105,715 | 4,067,800 | 24,925,701 | 2,238,500 |
| 20-Day Average Volume | 137,200 | 9,468,090 | 1,855,480 | 7,644,680 | 1,043,340 |
| Previous Close | 17.49 | 49.02 | 335.95 | 83.90 | 477.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.46 | 49.18 | 330.23 | 80.47 | 479.12 |
| 20-Day Raw Stochastic | 68.93% | 60.24% | 91.90% | 89.42% | 10.69% |
| 20-Day Relative Strength | 57.99% | 55.67% | 58.76% | 71.95% | 43.24% |
| Weighted Alpha | N/A | -10.22 | +27.84 | +18.32 | +28.48 |
| Today's Opinion | N/A | 72% Buy | 100% Buy | 88% Buy | 24% Buy |
| Previous Opinion | N/A | 56% Buy | 96% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | N/A | 40% Buy | 88% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.79% since 09/13/24 | +0.57% since 09/13/24 | +1.48% since 09/13/24 | +1.36% since 09/13/24 | -4.21% since 09/13/24 |
| Low | 16.23 on 09/20/24 | 48.78 on 09/18/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 463.81 on 09/20/24 |
| High | 17.79 on 09/17/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +26.10% since 08/20/24 | +0.88% since 08/20/24 | +2.69% since 08/20/24 | +12.29% since 08/20/24 | -4.61% since 08/20/24 |
| Low | 12.68 on 08/22/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 460.69 on 09/11/24 |
| High | 17.79 on 09/17/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +12.35% since 06/20/24 | +20.39% since 06/20/24 | +8.87% since 06/20/24 | +22.56% since 06/20/24 | -1.37% since 06/20/24 |
| Low | 10.80 on 08/12/24 | 39.35 on 07/05/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 458.04 on 08/13/24 |
| High | 17.79 on 09/17/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | N/A since 05/31/24 | -4.76% since 03/20/24 | +23.56% since 03/20/24 | +13.46% since 03/20/24 | +12.81% since 03/20/24 |
| Low | 10.80 on 08/12/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 18.95 on 06/05/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 253,185 | 99,368,440 | 180,215,344 | 104,527,072 | 123,323,528 |
| Shares Outstanding, K | 14,476 | 2,027,100 | 536,435 | 1,245,853 | 258,053 |
| Annual Sales | 1,800,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -241,360,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 100,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | 1,858,011,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | N/A | 0.46 | 0.61 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 125.48 on 08/13/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/12/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.31 | 17.90 | 17.85 | 0.00 |